The shock of the death of a child in the USA, just 13 years old, which ended after he was vaccinated against the coronavirus.
U.S. media reported Thursday that a boy from Saginaw County, Michigan, died of heart failure three days after receiving the second dose of the COVID-19 vaccine.
It is not clear which vaccine he received, but concerns are widespread worldwide.
Four days ago, federal health officials said they were investigating whether a COVID-19 vaccine caused the death of a 13-year-old boy in Saginaw, Michigan last week.
The boy died on June 17, three days after receiving the second dose of COVID-19 vaccine, according to the local Department of Health.
The Ministry of Health did not specify whether the boy received the Pfizer or Moderna vaccine and whether he had underlying health conditions.
More than 1,200 cases of myocarditis and pericarditis in the US after vaccination with Pfizer and Moderna
The US Centers for Disease Control and Prevention (CDIP) Advisory Committee on Immunization Practices (ACIP) has concluded that there is a “possible link” between COVID-19 mRNA vaccines (Pfizer / BioNTech and Moderna) and cases of myocardial infarction and myocarditis. ).
In addition, there appears to be a higher incidence of the disease in the younger, predominantly in men, and it occurs more frequently several days after the second dose.
Myocarditis leads to inflammation of the heart muscle, while pericarditis causes inflammation of the heart membrane. Symptoms associated with the diagnosis include chest pain, shortness of breath and a fast heartbeat or a throbbing sensation in the chest. In most cases, it can be treated with a range of non-steroidal anti-inflammatory drugs (some need steroids.) The majority of patients have made a seemingly complete recovery.
“The clinical presentation of cases of myocarditis after vaccination was clear, occurring more often within a week of the second dose, with chest pain being the most common symptom,” said Dr. Grace Lee, president of ACIP.
According to Tom Shimabukuro, deputy director of the CDC Immune Security Bureau, the agency has received reports of 1,226 cases of myocarditis, of which 827 (or 67.5%) occurred after the second dose of mRNA vaccine. This translates to about 12.6 cases per 1 million doses administered (approximately one in 80,000). Among the 1,226 patients, 484 were under 29 years old and two-thirds were men.
The US Food and Drug Administration (FDA) will add a warning to newsletters about these vaccines, and medical experts will investigate why these side effects occur.
With the demand for schools fully open in the fall, federal, state and local officials are pushing the FDA to approve vaccines for children under 12 years of age. However, scientists have drawn attention because there is limited data on the safety of vaccines for younger age groups, which require more rigorous study.
According to an ACIP report of June 11, 2021, where cases were broken down by age group, between the ages of 16 and 17 who received 2.3 million doses, there were 79 cases of myocarditis or pericarditis reported through the vaccine adverse reaction reporting system. of the federal government (VAERS).
This is a much higher rate than the expected 2 to 19 cases. For 18-24 year olds, who had received 9.8 million doses, 196 cases of myocarditis and pericarditis were reported, compared to the expected 8 to 83 cases.
